Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,023 public trials 2,029 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Elotuzumab, Lenalidomide and Dexamethasone in Treatment of Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients

NCT02843074

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Center for Cancer and Blood Disorders Bethesda, Maryland, United States
  • HCA Midwest Health/Research Medical Center Kansas City, Missouri, United States
  • Nebraska Methodist Hospital Omaha, Nebraska, United States
View Trial Details
Completed

Patient-individualized Peptide Vaccination Based on Tumor-specific Mutations in Children and Young Adults With Primary/Relapsed ALL

NCT03559413

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • University Medical Center for Children and Adolescents Heidelberg Heidelberg, Baden-Wurttemberg, Germany
  • University Children's Hospital Tübingen Tübingen, Baden-Wurttemberg, Germany
  • University Children's Hospital Munich, Center for Pediatric Hematology and Oncology München, Bavaria, Germany
  • University Hospital Düsseldorf, Clinic for Pediatric Oncology, Hematology and Clinical Immunology Düsseldorf, North Rhine-Westphalia, Germany
View Trial Details
Completed

Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational)

NCT02181738

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations
  • Local Institution - 0030 Los Angeles, California, United States
  • Local Institution - 0009 Los Angeles, California, United States
  • Local Institution - 0001 Atlanta, Georgia, United States
  • Local Institution - 0002 Boston, Massachusetts, United States
View all 38 locations
View Trial Details
Completed

Rhu-pGSN for Severe Covid-19 Pneumonia

NCT04358406

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +26 more
Locations
  • Spitalul Clinic de Boli Infecţioase şi Pneumoftiziologie Timișoara, Romania
  • Sant Joan de Reus SAM University Hospital Reus, Spain
  • Hospital Universitari de Tarragona Joan XXIII Tarragona, Spain
View Trial Details

Related conditions